DEXCOM INC (1DXCM.MI) Stock Fundamental Analysis

BIT:1DXCM • US2521311074

61.19 EUR
-1.11 (-1.78%)
Last: Feb 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to 1DXCM. 1DXCM was compared to 65 industry peers in the Health Care Equipment & Supplies industry. 1DXCM scores excellent on profitability, but there are some minor concerns on its financial health. 1DXCM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year 1DXCM was profitable.
  • 1DXCM had a positive operating cash flow in the past year.
  • 1DXCM had positive earnings in 4 of the past 5 years.
  • 1DXCM had a positive operating cash flow in 4 of the past 5 years.
1DXCM.MI Yearly Net Income VS EBIT VS OCF VS FCF1DXCM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of 1DXCM (9.61%) is better than 84.38% of its industry peers.
  • 1DXCM has a better Return On Equity (26.44%) than 90.63% of its industry peers.
  • 1DXCM's Return On Invested Capital of 15.72% is amongst the best of the industry. 1DXCM outperforms 93.75% of its industry peers.
  • 1DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is in line with the industry average of 9.57%.
  • The 3 year average ROIC (11.25%) for 1DXCM is below the current ROIC(15.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.61%
ROE 26.44%
ROIC 15.72%
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1DXCM.MI Yearly ROA, ROE, ROIC1DXCM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

1.3 Margins

  • The Profit Margin of 1DXCM (15.96%) is better than 85.94% of its industry peers.
  • In the last couple of years the Profit Margin of 1DXCM has grown nicely.
  • 1DXCM's Operating Margin of 18.41% is fine compared to the rest of the industry. 1DXCM outperforms 79.69% of its industry peers.
  • In the last couple of years the Operating Margin of 1DXCM has grown nicely.
  • Looking at the Gross Margin, with a value of 60.20%, 1DXCM is in line with its industry, outperforming 57.81% of the companies in the same industry.
  • 1DXCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.41%
PM (TTM) 15.96%
GM 60.2%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
1DXCM.MI Yearly Profit, Operating, Gross Margins1DXCM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1DXCM is creating some value.
  • 1DXCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1DXCM.MI Yearly Shares Outstanding1DXCM.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1DXCM.MI Yearly Total Debt VS Total Assets1DXCM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • 1DXCM has an Altman-Z score of 5.23. This indicates that 1DXCM is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.23, 1DXCM belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
  • The Debt to FCF ratio of 1DXCM is 2.36, which is a good value as it means it would take 1DXCM, 2.36 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 2.36, 1DXCM is doing good in the industry, outperforming 73.44% of the companies in the same industry.
  • A Debt/Equity ratio of 0.47 indicates that 1DXCM is not too dependend on debt financing.
  • 1DXCM has a Debt to Equity ratio (0.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.36
Altman-Z 5.23
ROIC/WACC1.7
WACC9.23%
1DXCM.MI Yearly LT Debt VS Equity VS FCF1DXCM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

  • 1DXCM has a Current Ratio of 1.56. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.56, 1DXCM is in line with its industry, outperforming 48.44% of the companies in the same industry.
  • A Quick Ratio of 1.38 indicates that 1DXCM should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.38, 1DXCM is in the better half of the industry, outperforming 67.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.38
1DXCM.MI Yearly Current Assets VS Current Liabilites1DXCM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.67% over the past year.
  • 1DXCM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.10% yearly.
EPS 1Y (TTM)26.67%
EPS 3Y33.93%
EPS 5Y22.1%
EPS Q2Q%51.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.12%

3.2 Future

  • Based on estimates for the next years, 1DXCM will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.26% on average per year.
  • Based on estimates for the next years, 1DXCM will show a quite strong growth in Revenue. The Revenue will grow by 12.21% on average per year.
EPS Next Y20.81%
EPS Next 2Y20.72%
EPS Next 3Y21.95%
EPS Next 5Y19.26%
Revenue Next Year12.81%
Revenue Next 2Y12.84%
Revenue Next 3Y13.05%
Revenue Next 5Y12.21%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1DXCM.MI Yearly Revenue VS Estimates1DXCM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
1DXCM.MI Yearly EPS VS Estimates1DXCM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • 1DXCM is valuated quite expensively with a Price/Earnings ratio of 34.77.
  • 1DXCM's Price/Earnings ratio is in line with the industry average.
  • 1DXCM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.19.
  • 1DXCM is valuated quite expensively with a Price/Forward Earnings ratio of 28.75.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1DXCM is on the same level as its industry peers.
  • 1DXCM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 34.77
Fwd PE 28.75
1DXCM.MI Price Earnings VS Forward Price Earnings1DXCM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1DXCM indicates a slightly more expensive valuation: 1DXCM is more expensive than 62.50% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, 1DXCM is valued a bit cheaper than 67.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.66
EV/EBITDA 24.17
1DXCM.MI Per share data1DXCM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • 1DXCM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • 1DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1DXCM's earnings are expected to grow with 21.95% in the coming years.
PEG (NY)1.67
PEG (5Y)1.57
EPS Next 2Y20.72%
EPS Next 3Y21.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for 1DXCM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DEXCOM INC

BIT:1DXCM (2/3/2026, 7:00:00 PM)

61.19

-1.11 (-1.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners99.77%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap23.87B
Revenue(TTM)N/A
Net Income(TTM)720.70M
Analysts84.32
Price Target74.79 (22.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)-15.49%
PT rev (3m)-15.49%
EPS NQ rev (1m)0.29%
EPS NQ rev (3m)0.29%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)-0.07%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 34.77
Fwd PE 28.75
P/S 6.27
P/FCF 26.66
P/OCF 19.55
P/B 10.38
P/tB 10.79
EV/EBITDA 24.17
EPS(TTM)1.76
EY2.88%
EPS(NY)2.13
Fwd EY3.48%
FCF(TTM)2.3
FCFY3.75%
OCF(TTM)3.13
OCFY5.12%
SpS9.76
BVpS5.89
TBVpS5.67
PEG (NY)1.67
PEG (5Y)1.57
Graham Number15.28
Profitability
Industry RankSector Rank
ROA 9.61%
ROE 26.44%
ROCE 19.96%
ROIC 15.72%
ROICexc 77.75%
ROICexgc 88.6%
OM 18.41%
PM (TTM) 15.96%
GM 60.2%
FCFM 23.51%
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.36
Debt/EBITDA 1.2
Cap/Depr 158.02%
Cap/Sales 8.55%
Interest Coverage 250
Cash Conversion 134.63%
Profit Quality 147.34%
Current Ratio 1.56
Quick Ratio 1.38
Altman-Z 5.23
F-Score5
WACC9.23%
ROIC/WACC1.7
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)26.67%
EPS 3Y33.93%
EPS 5Y22.1%
EPS Q2Q%51.11%
EPS Next Y20.81%
EPS Next 2Y20.72%
EPS Next 3Y21.95%
EPS Next 5Y19.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.12%
Revenue Next Year12.81%
Revenue Next 2Y12.84%
Revenue Next 3Y13.05%
Revenue Next 5Y12.21%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year73.63%
EBIT Next 3Y36.37%
EBIT Next 5Y30.37%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%

DEXCOM INC / 1DXCM.MI FAQ

Can you provide the ChartMill fundamental rating for DEXCOM INC?

ChartMill assigns a fundamental rating of 6 / 10 to 1DXCM.MI.


Can you provide the valuation status for DEXCOM INC?

ChartMill assigns a valuation rating of 4 / 10 to DEXCOM INC (1DXCM.MI). This can be considered as Fairly Valued.


What is the profitability of 1DXCM stock?

DEXCOM INC (1DXCM.MI) has a profitability rating of 8 / 10.


How financially healthy is DEXCOM INC?

The financial health rating of DEXCOM INC (1DXCM.MI) is 6 / 10.


Can you provide the expected EPS growth for 1DXCM stock?

The Earnings per Share (EPS) of DEXCOM INC (1DXCM.MI) is expected to grow by 20.81% in the next year.